{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:18:36Z","timestamp":1793830716495,"version":"4.6.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T00:00:00Z","timestamp":1691107200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T00:00:00Z","timestamp":1691107200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Science and Technology Innovation Project of Putuo District Health System","award":["No. ptkwws202305, No. ptkwws202307"],"award-info":[{"award-number":["No. ptkwws202305, No. ptkwws202307"]}]},{"name":"One Hundred Talents Project of Putuo Hospital, Shanghai University of Traditional Chinese Medicine","award":["No. 2022-RCQH-03"],"award-info":[{"award-number":["No. 2022-RCQH-03"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>HPV screening tests may improve cervical cancer risk stratification and better guide decisions about follow-up with colposcopy\/biopsy. This study aimed to estimate the risk of cervical intraepithelial neoplasia grade 2 or worse (CIN2+) among women with oncogenic HPV types and evaluate the performance of colposcopy in the diagnosis of histologic CIN2\u2009+\u2009at Putuo Hospital, Shanghai, China.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This cross-sectional survey was conducted from February 2020 to December 2022 among women who were referred to colposcopy. Women with high-risk (HR) HPV-positive, cytology testing and colposcopy-directed biopsy were included.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Univariate and multivariate analysis indicated that high-grade colposcopic impression ((OR, 17.61%, 95%CI: 11.54\u201326.85%) was associated with the highest risk for detecting CIN2+, followed by HSIL\u2009+\u2009cytology (OR, 6.90%, 95%CI: 3.56\u201313.37%) and HPV16\/18 positive (OR, 2.91%, 95%CI: 2.12\u20133.99%). Overall, CIN2\u2009+\u2009was detected in 14.6% of 2007 women. HPV16\/18 had higher CIN2\u2009+\u2009risks than other HR-HPV genotypes (30.1% vs. 10.2%, <jats:italic>P<\/jats:italic>&lt;0.001). Among women with low-grade cytology, 24.1% had CIN2+, and the risks for HPV16\/18 (58.2%) were higher than for other HR-HPV(16.8%). For those with high-grade cytology, there was no significant difference between HPV groups ( 75.0% vs. 72.9%, <jats:italic>P<\/jats:italic>\u2009&gt;\u20090.05). The diagnostic performance of colposcopy in diagnosis of CIN2\u2009+\u2009by senior and junior colposcopists was comparable.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The results indicated that referral to colposcopy is recommended in managing women with HR-HPV positive, and colposcopic impressions provide key clues for identification CIN2+.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12905-023-02538-2","type":"journal-article","created":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T17:01:39Z","timestamp":1691168499000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Detection of cervical high-grade squamous intraepithelial lesions and assessing diagnostic performance of colposcopy among women with oncogenic HPV"],"prefix":"10.1186","volume":"23","author":[{"given":"Xiaoxiao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenfen","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunzhi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinpei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengzhe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongrong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangdong","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,4]]},"reference":[{"issue":"19","key":"2538_CR1","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1093\/jnci\/djq356","volume":"102","author":"SK Kj\u00e6r","year":"2010","unstructured":"Kj\u00e6r SK, Frederiksen K, Munk C, Iftner T. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence. J Natl Cancer I. 2010;102(19):1478\u201388.","journal-title":"J Natl Cancer I"},{"key":"2538_CR2","doi-asserted-by":"crossref","unstructured":"Castle PE, Rodr\u00edguez AC, Burk RD, Herrero R, Wacholder S, Alfaro M, Morales J, Guillen D, Sherman ME, Solomon D. Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study. BMJ. 2009;339, b2569.","DOI":"10.1136\/bmj.b2569"},{"issue":"9916","key":"2538_CR3","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","volume":"383","author":"G Ronco","year":"2014","unstructured":"Ronco G, Dillner J, Elfstr\u00f6m KM, Tunesi S, Snijders PJ, Arbyn M, Kitchener H, Segnan N, Gilham C, Giorgi-Rossi P. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four european randomised controlled trials. Lancet. 2014;383(9916):524\u201332.","journal-title":"Lancet"},{"issue":"11","key":"2538_CR4","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1038\/s41416-020-0790-1","volume":"122","author":"D Hashim","year":"2020","unstructured":"Hashim D, Enges\u00e6ter B, Baadstrand Skare G, Castle PE, Bj\u00f8rge T, Trop\u00e9 A, Nyg\u00e5rd M. Real-world data on cervical cancer risk stratification by cytology and HPV genotype to inform the management of HPV-positive women in routine cervical screening. Brit J Cancer. 2020;122(11):1715\u201323.","journal-title":"Brit J Cancer"},{"issue":"1","key":"2538_CR5","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1001\/jama.2018.7464","volume":"320","author":"GS Ogilvie","year":"2018","unstructured":"Ogilvie GS, van Niekerk D, Krajden M, Smith LW, Cook D, Gondara L, Ceballos K, Quinlan D, Lee M, Martin RE. Effect of screening with primary cervical HPV testing vs cytology testing on high-grade cervical intraepithelial neoplasia at 48 months: the HPV FOCAL randomized clinical trial. JAMA. 2018;320(1):43\u201352.","journal-title":"JAMA"},{"issue":"1","key":"2538_CR6","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/S1470-2045(11)70296-0","volume":"13","author":"DC Rijkaart","year":"2012","unstructured":"Rijkaart DC, Berkhof J, Rozendaal L, van Kemenade FJ, Bulkmans NW, Heideman DA, Kenter GG, Cuzick J, Snijders PJ, Meijer CJ. Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial. Lancet Oncol. 2012;13(1):78\u201388.","journal-title":"Lancet Oncol"},{"issue":"2","key":"2538_CR7","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ygyno.2014.11.076","volume":"136","author":"TC Wright","year":"2015","unstructured":"Wright TC, Stoler MH, Behrens CM, Sharma A, Zhang G, Wright TL. Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test. Gynecol Oncol. 2015;136(2):189\u201397.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"2538_CR8","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/S1470-2045(09)70385-7","volume":"11","author":"PE Castle","year":"2010","unstructured":"Castle PE, Katki HA. Benefits and risks of HPV testing in cervical cancer screening. Lancet Oncol. 2010;11(3):214\u201315.","journal-title":"Lancet Oncol"},{"issue":"5","key":"2538_CR9","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/S1470-2045(11)70078-X","volume":"12","author":"M Kocken","year":"2011","unstructured":"Kocken M, Helmerhorst TJ, Berkhof J, Louwers JA, Nobbenhuis MA, Bais AG, Hogewoning CJ, Zaal A, Verheijen RH, Snijders PJ. Risk of recurrent high-grade cervical intraepithelial neoplasia after successful treatment: a long-term multi-cohort study. The lancet Oncol. 2011;12(5):441\u201350.","journal-title":"The lancet Oncol"},{"issue":"3","key":"2538_CR10","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.ygyno.2020.08.025","volume":"159","author":"G Bogani","year":"2020","unstructured":"Bogani G, Di Donato V, Sopracordevole F, Ciavattini A, Ghelardi A, Lopez S, Simoncini T, Plotti F, Casarin J, Serati M. Recurrence rate after loop electrosurgical excision procedure (LEEP) and laser conization: a 5-year follow-up study. Gynecol Oncol. 2020;159(3):636\u201341.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"2538_CR11","doi-asserted-by":"publisher","first-page":"698","DOI":"10.3390\/vaccines11030698","volume":"11","author":"A Giannini","year":"2023","unstructured":"Giannini A, Di Donato V, Sopracordevole F, Ciavattini A, Ghelardi A, Vizza E, D\u2019Oria O, Simoncini T, Plotti F, Casarin J. Outcomes of High-Grade cervical dysplasia with positive margins and HPV persistence after cervical conization. Vaccines. 2023;11(3):698.","journal-title":"Vaccines"},{"issue":"1","key":"2538_CR12","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1186\/s12885-022-09498-0","volume":"22","author":"B Wei","year":"2022","unstructured":"Wei B, Zhang B, Xue P, Seery S, Wang J, Li Q, Jiang Y, Qiao Y. Improving colposcopic accuracy for cervical precancer detection: a retrospective multicenter study in China. BMC Cancer. 2022;22(1):388.","journal-title":"BMC Cancer"},{"issue":"1","key":"2538_CR13","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1186\/s12885-022-10030-7","volume":"22","author":"N Dorji","year":"2022","unstructured":"Dorji N, Tshering S, Choden S, Chhetri M, Bhujel D, Wangden T, Pradhan B, Bhutia PC, Tshomo U. Evaluation of the diagnostic performance of colposcopy in the diagnosis of histologic cervical intraepithelial neoplasia 2+(CIN2+). BMC Cancer. 2022;22(1):930.","journal-title":"BMC Cancer"},{"issue":"8","key":"2538_CR14","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.3390\/diagnostics12081947","volume":"12","author":"L Ple\u015f","year":"2022","unstructured":"Ple\u015f L, Radosa J-C, Sima R-M, Chicea R, Olaru O-G, Poenaru M-O. The Accuracy of Cytology, Colposcopy and Pathology in evaluating precancerous cervical lesions. Diagnostics. 2022;12(8):1947.","journal-title":"Diagnostics"},{"issue":"10","key":"2538_CR15","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.3390\/diagnostics12102436","volume":"12","author":"FA Stuebs","year":"2022","unstructured":"Stuebs FA, Dietl AK, Behrens A, Adler W, Geppert C, Hartmann A, Kn\u00f6ll A, Beckmann MW, Mehlhorn G, Schulmeyer CE. Concordance rate of Colposcopy in detecting cervical intraepithelial lesions. Diagnostics. 2022;12(10):2436.","journal-title":"Diagnostics"},{"issue":"3","key":"2538_CR16","doi-asserted-by":"publisher","first-page":"463","DOI":"10.31083\/j.ejgo.2021.03.2347","volume":"42","author":"F Liu","year":"2021","unstructured":"Liu F, Zhang Y, Xia X, Han J, Hu D. Diagnostic value of different colposcopy evaluation methods for high-grade squamous intraepithelial lesions and cervical cancer. Eur J Gynaecol Oncol. 2021;42(3):463\u20139.","journal-title":"Eur J Gynaecol Oncol"},{"issue":"1","key":"2538_CR17","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12985-022-01879-y","volume":"19","author":"X Li","year":"2022","unstructured":"Li X, Xiang F, Dai J, Zhang T, Chen Z, Zhang M, Wu R, Kang X. Prevalence of cervicovaginal human papillomavirus infection and genotype distribution in Shanghai, China. Virol J. 2022;19(1):146.","journal-title":"Virol J"},{"issue":"16","key":"2538_CR18","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","volume":"287","author":"D Solomon","year":"2002","unstructured":"Solomon D, Davey D, Kurman R, Moriarty A, O\u2019Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright T Jr. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA. 2002;287(16):2114\u20139.","journal-title":"JAMA"},{"issue":"11","key":"2538_CR19","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1128\/JCM.05552-11","volume":"49","author":"D Heideman","year":"2011","unstructured":"Heideman D, Hesselink A, Berkhof J, Van Kemenade F, Melchers W, Daalmeijer NF, Verkuijten M, Meijer C, Snijders P. Clinical validation of the cobas 4800 HPV test for cervical screening purposes. J Clin Microbiol. 2011;49(11):3983\u20135.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"2538_CR20","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1097\/AOG.0b013e318254f90c","volume":"120","author":"J Bornstein","year":"2012","unstructured":"Bornstein J, Bentley J, B\u00f6sze P, Girardi F, Haefner H, Menton M, Perrotta M, Prendiville W, Russell P, Sideri M. 2011 colposcopic terminology of the International Federation for Cervical Pathology and Colposcopy. Obstet Gynecol. 2012;120(1):166\u201372.","journal-title":"Obstet Gynecol"},{"issue":"5","key":"2538_CR21","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1111\/ajo.13367","volume":"61","author":"FH Chin","year":"2021","unstructured":"Chin FH, Wrede CDH, Richards A, Steele A, Vicario E, McNally OM, Tan JH. Primary HPV cervical screening. Clinical audit of outcomes of women seen at a tertiary referral centre for colposcopy in Australia. Aust N J Obstet Gyn. 2021;61(5):750\u20138.","journal-title":"Aust N J Obstet Gyn"},{"issue":"7","key":"2538_CR22","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1002\/cncy.22573","volume":"130","author":"X Tao","year":"2022","unstructured":"Tao X, Zhang H, Zhang H, Xiao Y, Zhong F, Zhou X, Cong Q, Sui L, Zhao C. The clinical utility of extended high-risk HPV genotyping in risk\u2010stratifying women with L\u2010SIL cytology: a retrospective study of 8726 cases. Cancer Cytopathol. 2022;130(7):542\u201350.","journal-title":"Cancer Cytopathol"},{"issue":"12","key":"2538_CR23","doi-asserted-by":"publisher","first-page":"729","DOI":"10.3390\/v10120729","volume":"10","author":"AC Chrysostomou","year":"2018","unstructured":"Chrysostomou AC, Stylianou DC, Constantinidou A, Kostrikis LG. Cervical cancer screening programs in Europe: the transition towards HPV vaccination and population-based HPV testing. Viruses. 2018;10(12):729.","journal-title":"Viruses"},{"key":"2538_CR24","doi-asserted-by":"publisher","first-page":"F88","DOI":"10.1016\/j.vaccine.2012.06.095","volume":"30","author":"M Arbyn","year":"2012","unstructured":"Arbyn M, Ronco G, Anttila A, Meijer CJ, Poljak M, Ogilvie G, Koliopoulos G, Naucler P, Sankaranarayanan R, Peto J. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer. Vaccine. 2012;30:F88\u2013F99.","journal-title":"Vaccine"},{"key":"2538_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-019-1460-0","volume":"17","author":"CA Aitken","year":"2019","unstructured":"Aitken CA, van Agt HM, Siebers AG, van Kemenade FJ, Niesters HG, Melchers WJ, Vedder JE, Schuurman R, van den Brule AJ, van der Linden HC. Introduction of primary screening using high-risk HPV DNA detection in the dutch cervical cancer screening programme: a population-based cohort study. BMC Med. 2019;17:1\u201314.","journal-title":"BMC Med"},{"issue":"4","key":"2538_CR26","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1309\/AJCPTUS5EXAS6DKZ","volume":"136","author":"TC Wright Jr","year":"2011","unstructured":"Wright TC Jr, Stoler MH, Sharma A, Zhang G, Behrens C, Wright TL. Evaluation of HPV-16 and HPV-18 genotyping for the triage of women with high-risk HPV + cytology-negative results. Am J Clin Pathol. 2011;136(4):578\u201386.","journal-title":"Am J Clin Pathol"},{"issue":"16","key":"2538_CR27","doi-asserted-by":"publisher","first-page":"4149","DOI":"10.3390\/cancers13164149","volume":"13","author":"A Baumann","year":"2021","unstructured":"Baumann A, Henriques J, Selmani Z, Meurisse A, Lepiller Q, Vernerey D, Valmary-Degano S, Paget-Bailly S, Riethmuller D, Ramanah R. HPV16 load is a potential biomarker to predict risk of high-grade cervical lesions in high-risk HPV-infected women: a large longitudinal french hospital-based cohort study. Cancers. 2021;13(16):4149.","journal-title":"Cancers"},{"issue":"10","key":"2538_CR28","doi-asserted-by":"publisher","first-page":"687","DOI":"10.7326\/0003-4819-155-10-201111150-00376","volume":"155","author":"EP Whitlock","year":"2011","unstructured":"Whitlock EP, Vesco KK, Eder M, Lin JS, Senger CA, Burda BU. Liquid-based cytology and human papillomavirus testing to screen for cervical cancer: a systematic review for the US Preventive Services Task Force. Ann Intern Med. 2011;155(10):687\u201397.","journal-title":"Ann Intern Med"},{"issue":"11","key":"2538_CR29","doi-asserted-by":"publisher","first-page":"3068","DOI":"10.1002\/ijc.33128","volume":"147","author":"A Farnsworth","year":"2020","unstructured":"Farnsworth A, Roberts JM, Garland SM, Crescini J, Kaldor JM, Machalek DA. Detection of high-grade cervical disease among women referred directly to colposcopy after a positive HPV screening test varies with age and cytology findings. Int J Cancer. 2020;147(11):3068\u201374.","journal-title":"Int J Cancer"},{"issue":"11","key":"2538_CR30","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.3390\/diagnostics12112585","volume":"12","author":"P Xue","year":"2022","unstructured":"Xue P, Seery S, Li Q, Jiang Y, Qiao Y. Risk-based colposcopy for cervical precancer detection: a cross-sectional Multicenter Study in China. Diagnostics. 2022;12(11):2585.","journal-title":"Diagnostics"},{"key":"2538_CR31","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1007\/s00404-020-05740-x","volume":"302","author":"Y Ruan","year":"2020","unstructured":"Ruan Y, Liu M, Guo J, Zhao J, Niu S, Li F. Evaluation of the accuracy of colposcopy in detecting high-grade squamous intraepithelial lesion and cervical cancer. Arch Gynecol Obstet. 2020;302:1529\u201338.","journal-title":"Arch Gynecol Obstet"},{"issue":"6","key":"2538_CR32","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1111\/ajo.12282","volume":"54","author":"I Ghosh","year":"2014","unstructured":"Ghosh I, Mittal S, Banerjee D, Singh P, Dasgupta S, Chatterjee S, Biswas J, Panda C, Basu P. Study of accuracy of colposcopy in VIA and HPV detection-based cervical cancer screening program. Aust NZ J Obstet Gyn. 2014;54(6):570\u20135.","journal-title":"Aust NZ J Obstet Gyn"},{"issue":"2","key":"2538_CR33","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1097\/01.AOG.0000220505.18525.85","volume":"108","author":"JC Gage","year":"2006","unstructured":"Gage JC, Hanson VW, Abbey K, Dippery S, Gardner S, Kubota J, Schiffman M, Solomon D, Jeronimo J. Number of cervical biopsies and sensitivity of colposcopy. Obstet Gynecol. 2006;108(2):264\u201372.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"2538_CR34","doi-asserted-by":"publisher","first-page":"423","DOI":"10.7314\/APJCP.2014.15.1.423","volume":"15","author":"M Tatiyachonwiphut","year":"2014","unstructured":"Tatiyachonwiphut M, Jaishuen A, Sangkarat S, Laiwejpithaya S, Wongtiraporn W, Inthasorn P, Viriyapak B, Warnnissorn M. Agreement between colposcopic diagnosis and cervical pathology: Siriraj hospital experience. Asian Pac J Cancer P. 2014;15(1):423\u20136.","journal-title":"Asian Pac J Cancer P"},{"issue":"1","key":"2538_CR35","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s12885-023-10648-1","volume":"23","author":"D Qin","year":"2023","unstructured":"Qin D, Bai A, Xue P, Seery S, Wang J, Mendez MJG, Li Q, Jiang Y, Qiao Y. Colposcopic accuracy in diagnosing squamous intraepithelial lesions: a systematic review and meta-analysis of the International Federation of Cervical Pathology and Colposcopy 2011 terminology. BMC Cancer. 2023;23(1):187.","journal-title":"BMC Cancer"},{"issue":"3","key":"2538_CR36","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.ijgo.2015.07.024","volume":"132","author":"RA Mustafa","year":"2016","unstructured":"Mustafa RA, Santesso N, Khatib R, Mustafa AA, Wiercioch W, Kehar R, Gandhi S, Chen Y, Cheung A, Hopkins J. Systematic reviews and meta-analyses of the accuracy of HPV tests, visual inspection with acetic acid, cytology, and colposcopy. Int J Gynecol Obstet. 2016;132(3):259\u201365.","journal-title":"Int J Gynecol Obstet"},{"issue":"1","key":"2538_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12905-022-01592-6","volume":"22","author":"A Bai","year":"2022","unstructured":"Bai A, Wang J, Li Q, Seery S, Xue P, Jiang Y. Assessing colposcopic accuracy for high-grade squamous intraepithelial lesion detection: a retrospective, cohort study. BMC Womens Health. 2022;22(1):1\u20138.","journal-title":"BMC Womens Health"},{"issue":"3","key":"2538_CR38","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.ygyno.2020.06.496","volume":"158","author":"R Ara","year":"2020","unstructured":"Ara R, Khatun S, Pervin S, Jahan M, Shahera U, Ferdous J, Begum SA, Fatema S, Begum M, Nazneen S. Role of molecular biomarker human papilloma virus (HPV) E6 oncoprotein in cervical cancer screening. Gynecol Oncol. 2020;158(3):590\u20136.","journal-title":"Gynecol Oncol"},{"key":"2538_CR39","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ijgo.2005.01.009","volume":"89","author":"R Sankaranarayanan","year":"2005","unstructured":"Sankaranarayanan R, Gaffikin L, Jacob M, Sellors J, Robles S. A critical assessment of screening methods for cervical neoplasia. Int J Gynecol Obstet. 2005;89:4\u2013S12.","journal-title":"Int J Gynecol Obstet"},{"key":"2538_CR40","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s00404-018-4953-8","volume":"299","author":"FA Stuebs","year":"2019","unstructured":"Stuebs FA, Schulmeyer CE, Mehlhorn G, Gass P, Kehl S, Renner SK, Renner SP, Geppert C, Adler W, Hartmann A. Accuracy of colposcopy-directed biopsy in detecting early cervical neoplasia: a retrospective study. Arch Gynecol Obstet. 2019;299:525\u201332.","journal-title":"Arch Gynecol Obstet"},{"issue":"6","key":"2538_CR41","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.3390\/cancers13061224","volume":"13","author":"M Del Pino","year":"2021","unstructured":"Del Pino M, Angeles MA, Mart\u00ed C, Henere C, Munmany M, Marimon L, Saco A, Rakislova N, Ordi J, Torn\u00e9 A. Colposcopic impression has a key role in the estimation of the risk of HSIL\/CIN3. Cancers. 2021;13(6):1224.","journal-title":"Cancers"},{"issue":"6","key":"2538_CR42","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1097\/AOG.0000000000001777","volume":"128","author":"T Bj\u00f8rge","year":"2016","unstructured":"Bj\u00f8rge T, Skare GB, Bj\u00f8rge L, Trop\u00e9 A, L\u00f6nnberg S. Adverse pregnancy outcomes after treatment for cervical intraepithelial neoplasia. Obstet Gynecol. 2016;128(6):1265\u201373.","journal-title":"Obstet Gynecol"},{"issue":"10","key":"2538_CR43","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1111\/j.1471-0528.2012.03429.x","volume":"119","author":"C Simoens","year":"2012","unstructured":"Simoens C, Goffin F, Simon P, Barlow P, Antoine J, Foidart JM, Arbyn M. Adverse obstetrical outcomes after treatment of precancerous cervical lesions: a belgian multicentre study. BJOG-Int J Obstet Gy. 2012;119(10):1247\u201355.","journal-title":"BJOG-Int J Obstet Gy"},{"issue":"2","key":"2538_CR44","first-page":"233","volume":"73","author":"M Monti","year":"2020","unstructured":"Monti M, D\u2019Aniello D, Scopelliti A, Tibaldi V, Santangelo G, Colagiovanni V, Giannini A, Palaia I, Perniola G, Giancotti A. Relationship between cervical excisional treatment for cervical intraepithelial neoplasia and obstetrical outcome. Minerva Obstet Gynec. 2020;73(2):233\u201346.","journal-title":"Minerva Obstet Gynec"},{"issue":"20","key":"2538_CR45","doi-asserted-by":"publisher","first-page":"13176","DOI":"10.3390\/ijerph192013176","volume":"19","author":"B Pecorino","year":"2022","unstructured":"Pecorino B, D\u2019Agate MG, Scibilia G, Scollo P, Giannini A, Di Donna MC, Chiantera V, Lagan\u00e0 AS. Evaluation of Surgical Outcomes of Abdominal Radical Hysterectomy and Total Laparoscopic Radical Hysterectomy for Cervical Cancer: a retrospective analysis of data collected before the LACC Trial. Int J of Env Res Pub He. 2022;19(20):13176.","journal-title":"Int J of Env Res Pub He"},{"issue":"1","key":"2538_CR46","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.ygyno.2020.06.508","volume":"159","author":"J Casarin","year":"2020","unstructured":"Casarin J, Buda A, Bogani G, Fanfani F, Papadia A, Ceccaroni M, Malzoni M, Pellegrino A, Ferrari F, Greggi S. Predictors of recurrence following laparoscopic radical hysterectomy for early-stage cervical cancer: a multi-institutional study. Gynecol Oncol. 2020;159(1):164\u201370.","journal-title":"Gynecol Oncol"},{"key":"2538_CR47","doi-asserted-by":"crossref","unstructured":"Bogani G, Cromi A, Uccella S, Serati M, Casarin J, Pinelli C, Nardelli F, Ghezzi F. Nerve-sparing versus conventional laparoscopic radical hysterectomy: a minimum 12 months\u2019 follow-up study. Int J Gynecol Cancer. 2014, 24(4).","DOI":"10.1097\/IGC.0000000000000110"},{"key":"2538_CR48","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ygyno.2023.04.030","volume":"174","author":"V Di Donato","year":"2023","unstructured":"Di Donato V, Bogani G, Casarin J, Ghezzi F, Malzoni M, Falcone F, Petrillo M, Capobianco G, Cal\u00f2 F, D\u2019Aug\u00e8 TG. Ten-year outcomes following laparoscopic and open abdominal radical hysterectomy for \u201clow-risk\u201d early-stage cervical cancer: a propensity-score based analysis. Gynecol Oncol. 2023;174:49\u201354.","journal-title":"Gynecol Oncol"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-023-02538-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-023-02538-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-023-02538-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T10:04:01Z","timestamp":1700388241000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-023-02538-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,4]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2538"],"URL":"https:\/\/doi.org\/10.1186\/s12905-023-02538-2","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,4]]},"assertion":[{"value":"3 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of Putuo Hospital, Shanghai University of Traditional Chinese Medicine (No. PTEC-A-2020-24-3). All methods were performed in accordance with the Declaration of Helsinki. The need for informed consent was waived by the IRB of Putuo Hospital due to the retrospective nature of archived datasets and fully anonymized personal information.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"411"}}